Fatal carboplatin-induced immune hemolytic anemia in a child with a brain tumor

Drug-induced immune hemolytic anemia (DIIHA) is an uncommon side effect of pharmacologic intervention. A rare mediator of DIIHA, carboplatin is an agent used to treat many pediatric cancers. We describe here, the first case of fatal carboplatin induced DIIHA in a pediatric patient and a brief review...

Descripción completa

Detalles Bibliográficos
Autores principales: Haley, Kristina M, Russell, Thomas B, Boshkov, Lynn, Leger, Regina M, Garratty, George, Recht, Michael, Nazemi, Kellie J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031206/
https://www.ncbi.nlm.nih.gov/pubmed/24868179
http://dx.doi.org/10.2147/JBM.S59192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031206/
https://www.ncbi.nlm.nih.gov/pubmed/24868179
http://dx.doi.org/10.2147/JBM.S59192

Ejemplares similares